Diabetes Injectable for Adults Shows Promise in Helping Obese Teens Lose Weight
A recently published report suggests that glucagon-like peptide-1 (GLP-1) receptor agonists, approved for adults with type 2 diabetes, also can help obese adolescents with weight loss. Treatment with exenatide caused a 2.7% greater reduction in BMI than placebo.
Find out more about the study and why it is considered promising.